Determination of POMC expression in MBH samples of scr shRNA and MeCP2 shRNA treated rats revealed that MeCP2 shRNA treatment increased POMC mRNA expression in AF but not in AD and PF rats (Fig. 4B). Here, MECP2 is linked to Alzheimer disease.